Publication | Closed Access

A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients

Translational MedicineSurgical OncologyOncologyHepatologyHepatocellular CarcinomaMedicineHistopathologyAfp LevelHepatitisPathologyLiver DiseaseLiver CancerBetter Staging SystemMolecular DiagnosticsTumor MicroenvironmentCancer ResearchRadiology